169 related articles for article (PubMed ID: 6357932)
1. Mechanism of the A/Ph.MC.S1 tumor graft rejection in syngeneic mice.
Zákány J; Jánossy T; Németh P; Chihara G; Fachet J; Petri G
Gan; 1983 Oct; 74(5):712-22. PubMed ID: 6357932
[TBL] [Abstract][Full Text] [Related]
2. The role of T cell sets in the rejection of a methylcholanthrene-induced sarcoma (S1509a) in syngeneic mice.
Bhan AK; Perry LL; Cantor H; McCluskey RT; Benacerraf B; Greene MI
Am J Pathol; 1981 Jan; 102(1):20-7. PubMed ID: 6970525
[TBL] [Abstract][Full Text] [Related]
3. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
Fortner GW; Kripke ML
J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
[TBL] [Abstract][Full Text] [Related]
4. [Current topics on tumor immunology].
Tachibana T
Gan No Rinsho; 1983 Oct; 29(13):1492-8. PubMed ID: 6608013
[TBL] [Abstract][Full Text] [Related]
5. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
Vaage J
Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
[No Abstract] [Full Text] [Related]
6. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages.
Harmel RP; zbar B
J Natl Cancer Inst; 1975 Apr; 54(4):989-92. PubMed ID: 1127729
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor lymph node cells from mice bearing methylcholanthrene-induced sarcomas.
Indrová M; Bubeník J
Neoplasma; 1979; 26(4):405-12. PubMed ID: 160510
[TBL] [Abstract][Full Text] [Related]
8. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
Fujimoto S; Greene MI; Sehon AH
J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
[TBL] [Abstract][Full Text] [Related]
9. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
Jurin M; Suit HD
Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
[No Abstract] [Full Text] [Related]
11. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
[TBL] [Abstract][Full Text] [Related]
12. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
Suga T; Shiio T; Maeda YY; Chihara G
Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
[TBL] [Abstract][Full Text] [Related]
14. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
[TBL] [Abstract][Full Text] [Related]
15. Dissociation between cytotoxic activity and delayed hypersensitivity against syngeneic or allogeneic tumor grafts.
Sato M; Nomoto K; Yano Y; Taniguchi K; Takeya K
Gan; 1976 Dec; 67(6):835-47. PubMed ID: 1088135
[TBL] [Abstract][Full Text] [Related]
16. Effect of lentinan on the production of migration inhibitory factor induced by syngeneic tumor in mice.
Zákány J; Chihara G; Fachet J
Int J Cancer; 1980 Dec; 26(6):783-8. PubMed ID: 7012047
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
Jurin M; Suit HD
Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
[No Abstract] [Full Text] [Related]
18. Tumor-specific resistance in mice detected by inhibition of macrophage migration.
Vaage J; Jones RD; Brown BW
Cancer Res; 1972 Apr; 32(4):680-7. PubMed ID: 4552377
[No Abstract] [Full Text] [Related]
19. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells.
Zbar B; Canti G; Rapp HJ; Ashley MP; Sukumar S; Bast RC
Cancer Res; 1980 Apr; 40(4):1036-42. PubMed ID: 7357533
[No Abstract] [Full Text] [Related]
20. Macrophage migration inhibition with mouse tumor antigens: properties of serum and peritoneal cells during tumor growth and after tumor loss.
Halliday WJ
Cell Immunol; 1972 Jan; 3(1):113-22. PubMed ID: 5061636
[No Abstract] [Full Text] [Related]
[Next] [New Search]
